These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. ISDD: A computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies. Hinderliter PM; Minard KR; Orr G; Chrisler WB; Thrall BD; Pounds JG; Teeguarden JG Part Fibre Toxicol; 2010 Nov; 7(1):36. PubMed ID: 21118529 [TBL] [Abstract][Full Text] [Related]
3. The delivered dose: Applying particokinetics to in vitro investigations of nanoparticle internalization by macrophages. Ahmad Khanbeigi R; Kumar A; Sadouki F; Lorenz C; Forbes B; Dailey LA; Collins H J Control Release; 2012 Sep; 162(2):259-66. PubMed ID: 22824784 [TBL] [Abstract][Full Text] [Related]
4. ISD3: a particokinetic model for predicting the combined effects of particle sedimentation, diffusion and dissolution on cellular dosimetry for in vitro systems. Thomas DG; Smith JN; Thrall BD; Baer DR; Jolley H; Munusamy P; Kodali V; Demokritou P; Cohen J; Teeguarden JG Part Fibre Toxicol; 2018 Jan; 15(1):6. PubMed ID: 29368623 [TBL] [Abstract][Full Text] [Related]
5. Dispersion characteristics of various metal oxide secondary nanoparticles in culture medium for in vitro toxicology assessment. Kato H; Fujita K; Horie M; Suzuki M; Nakamura A; Endoh S; Yoshida Y; Iwahashi H; Takahashi K; Kinugasa S Toxicol In Vitro; 2010 Apr; 24(3):1009-18. PubMed ID: 20006982 [TBL] [Abstract][Full Text] [Related]
6. In vitro nanoparticle dosimetry for adherent growing cell monolayers covering bottom and lateral walls. Böhmert L; König L; Sieg H; Lichtenstein D; Paul N; Braeuning A; Voigt A; Lampen A Part Fibre Toxicol; 2018 Oct; 15(1):42. PubMed ID: 30376850 [TBL] [Abstract][Full Text] [Related]
7. Influence of Silica Nanoparticle Density and Flow Conditions on Sedimentation, Cell Uptake, and Cytotoxicity. Yazdimamaghani M; Barber ZB; Hadipour Moghaddam SP; Ghandehari H Mol Pharm; 2018 Jun; 15(6):2372-2383. PubMed ID: 29719153 [TBL] [Abstract][Full Text] [Related]
8. A role for nanoparticle surface reactivity in facilitating pulmonary toxicity and development of a base set of hazard assays as a component of nanoparticle risk management. Warheit DB; Reed KL; Sayes CM Inhal Toxicol; 2009 Jul; 21 Suppl 1():61-7. PubMed ID: 19558235 [TBL] [Abstract][Full Text] [Related]
9. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Sayes CM; Reed KL; Warheit DB Toxicol Sci; 2007 May; 97(1):163-80. PubMed ID: 17301066 [TBL] [Abstract][Full Text] [Related]
10. Changing the dose metric for inhalation toxicity studies: short-term study in rats with engineered aerosolized amorphous silica nanoparticles. Sayes CM; Reed KL; Glover KP; Swain KA; Ostraat ML; Donner EM; Warheit DB Inhal Toxicol; 2010 Mar; 22(4):348-54. PubMed ID: 20001567 [TBL] [Abstract][Full Text] [Related]
11. Oxide nanoparticle uptake in human lung fibroblasts: effects of particle size, agglomeration, and diffusion at low concentrations. Limbach LK; Li Y; Grass RN; Brunner TJ; Hintermann MA; Muller M; Gunther D; Stark WJ Environ Sci Technol; 2005 Dec; 39(23):9370-6. PubMed ID: 16382966 [TBL] [Abstract][Full Text] [Related]
12. Physicochemical characterization and in vitro hemolysis evaluation of silver nanoparticles. Choi J; Reipa V; Hitchins VM; Goering PL; Malinauskas RA Toxicol Sci; 2011 Sep; 123(1):133-43. PubMed ID: 21652737 [TBL] [Abstract][Full Text] [Related]
13. Nominal and effective dosimetry of silica nanoparticles in cytotoxicity assays. Lison D; Thomassen LC; Rabolli V; Gonzalez L; Napierska D; Seo JW; Kirsch-Volders M; Hoet P; Kirschhock CE; Martens JA Toxicol Sci; 2008 Jul; 104(1):155-62. PubMed ID: 18400775 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of Toxicity Ranking for Metal Oxide Nanoparticles via an in Vitro Dosimetry Model. Liu R; Liu HH; Ji Z; Chang CH; Xia T; Nel AE; Cohen Y ACS Nano; 2015 Sep; 9(9):9303-13. PubMed ID: 26284985 [TBL] [Abstract][Full Text] [Related]
16. A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Johnston HJ; Hutchison G; Christensen FM; Peters S; Hankin S; Stone V Crit Rev Toxicol; 2010 Apr; 40(4):328-46. PubMed ID: 20128631 [TBL] [Abstract][Full Text] [Related]
17. The effect of shear flow on nanoparticle agglomeration and deposition in in vitro dynamic flow models. Grabinski C; Sharma M; Maurer E; Sulentic C; Mohan Sankaran R; Hussain S Nanotoxicology; 2016; 10(1):74-83. PubMed ID: 25961858 [TBL] [Abstract][Full Text] [Related]
18. In search of the most relevant parameter for quantifying lung inflammatory response to nanoparticle exposure: particle number, surface area, or what? Wittmaack K Environ Health Perspect; 2007 Feb; 115(2):187-94. PubMed ID: 17384763 [TBL] [Abstract][Full Text] [Related]
19. Modeling physicochemical interactions affecting in vitro cellular dosimetry of engineered nanomaterials: application to nanosilver. Mukherjee D; Leo BF; Royce SG; Porter AE; Ryan MP; Schwander S; Chung KF; Tetley TD; Zhang J; Georgopoulos PG J Nanopart Res; 2014 Oct; 16(10):2616. PubMed ID: 25598696 [TBL] [Abstract][Full Text] [Related]
20. Comparative cytotoxicity of nanosilver in human liver HepG2 and colon Caco2 cells in culture. Sahu SC; Zheng J; Graham L; Chen L; Ihrie J; Yourick JJ; Sprando RL J Appl Toxicol; 2014 Nov; 34(11):1155-66. PubMed ID: 24522958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]